Pancreatic Cancer Research

ResearcherUniversity of Rome Tor VergataNo recent work listed

Sara Calabretta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-1859-3995; OpenAlex author ID A5067269977. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells. Co-author DOI 10.1038/onc.2015.270↗
  2. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. First author DOI 10.1038/onc.2012.306↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gianfranco Delle Fave · 2 shared papers, 2013–2016 · strength 0.10
  2. Claudio Sette · 2 shared papers, 2013–2016 · strength 0.10
  3. Gabriele Capurso · 2 shared papers, 2013–2016 · strength 0.10
  4. Ilaria Passacantilli · 1 shared paper, 2016 · strength 0.06
  5. Volker Fendrich · 1 shared paper, 2016 · strength 0.06
  6. Laura Adesso · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.